Efficacy of Metformin in Preventing Diabetes in China
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1724 participants.
Also called NCT03441750
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 1,724 participants
- Sponsor
- Chinese Association of Geriatric Research
- Registry
-
NCT03441750
-
- Other papers using this trial's data
- Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03441750. Randomized; no masking; primary purpose prevention. Start 2017-04-25 (actual); primary completion 2021-06-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of Metformin in Preventing Diabetes in China
- Acronym
- ChinaDPP
- Condition
- PreDiabetes
- Intervention (Drug)
- metformin
- Intervention (Other)
- Standard lifestyle intervention
- Lead sponsor
- Chinese Association of Geriatric Research
Record details
- Record id
cardio:ct-nct03441750- Content hash
735594025495590758577622fc4cef99fa7c7970517d9dc944a57f8db62e66c1